Results 81 to 90 of about 18,807 (198)

An inherited defect in the C3 convertase, C3b,Bb, associated with glomerulonephritis [PDF]

open access: yes, 1983
An inherited defect in the C3 convertase, C3b,Bb, associated with glomerulonephritis. The control of the amplification C3 convertase, C3b,Bb, of the serum complement system has been found to be defective in five members of a family spanning three ...
Beischel, Linda   +4 more
core   +1 more source

A case of glomerulonephritis with dominant C3 with organized deposits complicated by non-tuberculous mycobacteria

open access: yesHuman Pathology Reports
We report a case of membranoproliferative glomerulonephritis (MPGN) with dominant C3 and uniquely organized deposits complicated by pulmonary non-tuberculous mycobacterial (NTM) infection.
Masanori Sudo   +11 more
doaj   +1 more source

C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy

open access: yesOrphanet Journal of Rare Diseases, 2019
Background Acquired or genetic abnormalities of the complement alternative pathway are the primary cause of C3glomerulopathy(C3G) but may occur in immune-complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) as well. Less is known about the
Nóra Garam   +60 more
doaj   +1 more source

Voclosporin‐induced gingival enlargement: A case report

open access: yesClinical Advances in Periodontics, Volume 16, Issue 2, Page 338-343, June 2026.
Abstract Background Drug‐influenced gingival enlargement (DIGE) is a recognized adverse effect of certain medications, particularly immunosuppressants like cyclosporin and tacrolimus. However, there have been no documented cases of DIGE associated with voclosporin, a newer calcineurin inhibitor used primarily to treat lupus nephritis.
Francesca Racca   +2 more
wiley   +1 more source

C3 nephritic factor can be associated with membranous glomerulonephritis. [PDF]

open access: yes, 2015
International audienceC3 nephritic factor (C3NeF) has been described in association with membranoproliferative glomerulonephritis and is involved in 80 % of cases of dense deposit disease.
Guigonis, Vincent   +6 more
core  

A Rare Presentation of Granulomatosis With Polyangiitis: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Granulomatosis with polyangiitis (GPA) is a rare ANCA‐associated necrotizing vasculitis that predominantly affects the respiratory tract and kidneys. Gastrointestinal involvement is uncommon, and pancreatic manifestations are exceedingly rare. Diffuse alveolar hemorrhage (DAH) represents a severe and potentially fatal complication. We report a
Anil Shahi   +2 more
wiley   +1 more source

Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies [PDF]

open access: yes, 2016
An enhanced understanding of the role of complement in the pathogenesis of membranoproliferative glomerulonephritis has led to reclassification of the latter into immunoglobulin-mediated and non-immunoglobulin-mediated disease.
Lionaki, S.   +2 more
core  

PPP2R3C serves as a negative regulator associated with reduced T cell hyperactivation and renal protection in lupus

open access: yesClinical and Translational Medicine, Volume 16, Issue 6, June 2026.
Downregulation of PPP2R3C in lupus CD4+ T cells unleashes JNK/c‑Jun and PLCγ1 signalling, driving calcium influx and inflammatory cytokine production. Reconstitution of PPP2R3C expression curbs T cell activation, lowers autoantibody levels and alleviates lupus nephritis, highlighting PPP2R3C as a promising therapeutic candidate. Abstract Background CD4+
Xuan Fang   +8 more
wiley   +1 more source

Shifting From Systemic to Precision‐Targeted Complement Therapies: Opportunities and Hurdles

open access: yesEuropean Journal of Immunology, Volume 56, Issue 6, June 2026.
Complement therapeutics have expanded considerably, but systemic inhibitors remain limited by infection risks, breakthrough events, and loss of physiological functions. Emerging targeted approaches aim for organ‐, tissue‐, or cell‐specific modulation of complement activity, potentially offering greater precision while reducing treatment burden and ...
Marco Mannes   +2 more
wiley   +1 more source

Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation [PDF]

open access: yes, 2015
Risk for atypical hemolytic uremic syndrome (aHUS) recurrence after renal transplantation is low with an isolated membrane cofactor protein mutation (MCP).
Frémeaux Bacchi, Véronique   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy